P. Smalley
Director/Board Member bei Valo Health LLC
Profil
P.
Adam Smalley is currently a Director at Valo Health, Inc. and a Senior Director-Credit Investments at Psp Investment, Inc. He also holds a Director position at Valo Health LLC.
Smalley completed his undergraduate degree at Bucknell University and earned an MBA from Columbia Business School.
Aktive Positionen von P. Smalley
| Unternehmen | Position | Beginn |
|---|---|---|
Valo Health LLC
 Valo Health LLC Packaged SoftwareTechnology Services Valo Health LLC operates as a drug discovery technology company. It offers cloud computing as well as longitudinal and human data to create an entirely new drug discovery and development process. The company was founded in 2019 and is headquartered in Boston, MA. | Director/Board Member | - |
| Psp Investment, Inc. | Corporate Officer/Principal | 01.05.2016 |
Valo Health, Inc.
 Valo Health, Inc. Financial ConglomeratesFinance Part of Valo Health LLC, Valo Health, Inc. operates as a development stage company. The private company is based in Boston, MA. The company was founded by David A. Berry. David A. Berry has been the CEO since incorporation. | Director/Board Member | 01.02.2021 |
Ausbildung von P. Smalley
| Bucknell University | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Valo Health, Inc.
Valo Health, Inc. Financial ConglomeratesFinance Part of Valo Health LLC, Valo Health, Inc. operates as a development stage company. The private company is based in Boston, MA. The company was founded by David A. Berry. David A. Berry has been the CEO since incorporation. | Finance |
| Psp Investment, Inc. | |
Valo Health LLC
Valo Health LLC Packaged SoftwareTechnology Services Valo Health LLC operates as a drug discovery technology company. It offers cloud computing as well as longitudinal and human data to create an entirely new drug discovery and development process. The company was founded in 2019 and is headquartered in Boston, MA. | Technology Services |
